
Mary M. Barna, PharmD
Advertisement
Articles by Mary M. Barna, PharmD


Alzheimer's disease represents a mounting public health problem and clinicians need a strong understanding of both the disease and its various treatment modalities.

When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.
Advertisement
Latest Updated Articles
Managing Opioid- Induced ConstipationSeptember 15th 2009
Alzheimer's Disease: Slowing Down the CourseMarch 1st 2009
Overactive Bladder Disease: Overcoming the Urge to GoJanuary 1st 2009
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
5